Proprietary AI analyst is now available
- Public Comps
- So-Young
So-Young Valuation Multiples
Discover So-Young's revenue and EBITDA valuation multiples and investment history, alongside public comparables like Hostelworld Group, PR TIMES, Freelance.com, Autostreets and more.
So-Young Overview
About So-Young
So-Young International Inc is an online destination for discovering, evaluating, and reserving medical aesthetic services in China. Its business model comprises four integrated components: professional content and its distribution through social media networks and its targeted media platforms in China, a social community characterized by signature user-generated content, Online reservation services for a medical aesthetic treatment, and the research, development, production, sales and agency of laser and other optoelectronic medical beauty equipment. It generates revenue from information services fees and reservation services fees from medical aesthetic service providers.
Founded
2014
HQ

Employees
1.8K
Website
Financials (LTM)
EV
$125M
Valuation Multiples
Start free trialSo-Young Financials
So-Young reported last 12-month revenue of $258M and negative EBITDA of ($25M).
In the same LTM period, So-Young generated $111M in gross profit, ($25M) in EBITDA losses, and had net loss of ($33M).
Revenue (LTM)
So-Young P&L
In the most recent fiscal year, So-Young reported revenue of $225M and EBITDA of ($27M).
So-Young is unprofitable as of last fiscal year, with gross margin of 48%, EBITDA margin of (12%), and net margin of (16%).
Financial data powered by Morningstar, Inc.
So-Young Stock Performance
So-Young has current market cap of $187M, and enterprise value of $125M.
Market Cap Evolution
So-Young's stock price is $1.86.
So-Young share price decreased by 4.6% in the last 30 days, and by 40.0% in the last year.
So-Young has an EPS (earnings per share) of $-0.35.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $125M | $187M | 0.0% | -4.6% | -31.9% | -40.0% | $-0.35 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSo-Young Valuation Multiples
So-Young trades at 0.5x EV/Revenue multiple, and (5.0x) EV/EBITDA.
EV / Revenue (LTM)
So-Young Financial Valuation Multiples
As of June 15, 2026, So-Young has market cap of $187M and EV of $125M.
So-Young has a P/E ratio of (5.6x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified So-Young Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


So-Young Margins & Growth Rates
So-Young grew revenue by 35% but EBITDA decreased by 17% in the last fiscal year.
In the most recent fiscal year, So-Young reported gross margin of 48%, EBITDA margin of (12%), and net margin of (16%).
So-Young Margins
So-Young Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
So-Young Operational KPIs
So-Young's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.
So-Young's Rule of 40 is 27% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
So-Young's Rule of X is 79% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
So-Young Competitors
So-Young competitors include Hostelworld Group, PR TIMES, Freelance.com, Autostreets, NusaTrip, Yatra Online, lastminute.com, One Career, Playboy and Port Inc..
Most So-Young public comparables operate across Online Content & News and Vertical Marketplaces.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1.7x | 1.6x | 8.1x | 7.5x | |||
| 2.3x | 2.1x | 5.4x | 5.4x | |||
| 0.2x | 0.2x | 4.8x | 5.9x | |||
| 2.1x | - | 9.7x | - | |||
| 143.4x | - | (247.1x) | - | |||
| 1.5x | 1.4x | 14.5x | 17.7x | |||
| 0.1x | 0.1x | 0.7x | 0.6x | |||
| 3.3x | 2.8x | 11.6x | - | |||
This data is available for Pro users. Sign up to see all So-Young competitors and their valuation data. Start Free Trial | ||||||
So-Young VC Funding History
Before going public, So-Young raised $229M in total equity funding, across 5 rounds.
Last private valuation of So-Young was $1B, after raising $70M in September 2018 from BOC International Holdings, Matrix Partners China, Orchid Asia Group Management, and 1 other investor.
So-Young Funding Rounds
Investments by So-Young
So-Young has invested in 3 companies to date.
Latest investment by So-Young was on September 9th 2024. So-Young invested in Junhemeng Biopharmaceutical in their $28M Series B round (EV/Revenue multiple available to Pro users).
Latest Investments by So-Young
| Description | Junhemeng Biopharmaceutical is a company developing synthetic biology products and recombinant protein drugs for endocrine disorders, neurology, anti-aging, and biomedical uses through engineered microbial systems. | Shanghai LinkedCare Information Technology is a Shanghai-based digital platform for consumer medical services targeting dental clinics and aesthetic institutions. It delivers integrated solutions for operations management, standardized diagnostics, marketing, mobile offices, and data-driven decisions. The platform automates full digital workflows to support revenue growth, risk mitigation, cost reduction, and efficiency gains in health management cycles. | BCC is a Seoul-based hospital dedicated to plastic and reconstructive surgery, featuring specialized centers for eye procedures, breast augmentation, facial contouring, liposuction, rhinoplasty and non-surgical injections. It operates 15 departments including scar revision, fat grafting and maxillofacial surgery, serving international patients from 30 countries with JCI-accredited facilities. BCC performs over 10,000 procedures annually using 3D simulation technology and post-operative care suites. |
| HQ Country | |||
| HQ City | Hangzhou | Shanghai | Beijing |
| Deal Date | 9 Sep 2024 | 23 Jun 2021 | 28 Sep 2017 |
| Round | Series B | Series D | Strategic investment |
| Raised | $28M | $100M | $8M |
| Investors | Hongsheng Capital; Oriza Holdings; SDIC Unity Capital; So-Young | Cowin Capital; Investcorp Capital; Jiawei Gan; Jinding Capital; Lightspeed China Partners; Matrix Partners China; Sheng Ye Capital; So-Young | So-Young |
| Valuation | undisclosed | undisclosed | undisclosed |
| EV/Revenue | |||
| EV/EBITDA | |||
This data is available for Pro users. Sign up to see all So-Young investments and their VC round multiples. Start Free Trial | |||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout So-Young
| Who are competitors of So-Young? | So-Young main competitors include Hostelworld Group, PR TIMES, Freelance.com, Autostreets, NusaTrip, Yatra Online, lastminute.com, One Career, Playboy, Port Inc.. |
See public comps similar to So-Young
Lists including So-Young
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
